Table 2.
Molecular targets and chemopreventive agents in the microenvironment.
Molecular targets | Chemopreventive agents |
---|---|
Oestrogen receptors | Tamoxifen; raloxifene; aroxifene |
Akt and NFκB | Curcumin; N-acetyl cysteine; silibinin; xanthohumol; deguelin; EGCG; resveratrol |
NRF2-KEAP1 | Sulphoraphane; oltipraz |
COX2 | Rofecoxib; celecoxib; EGCG |
COX1/2 | Aspirin and other NSAIDs |
Histone deacetylases | Sulphoraphane |
TGFβ pathway | CDDO-Imidazolide |
HIF1α | WGCG; resveratrol; apigenin; sulphoraphane |
STATs | CDDO-Imidazolide |
VEGF | Sulphoraphane; EGCG; fenretinide |
Some of the specific targets in the microenvironment and specific agents that interact with these targets: CDDO: 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid; COX2: cyclooxygenase 2; EGCG: epigallocatechin-3-gallate; HIF1α: hypoxia-inducible factor 1α; KEAP1: kelch-like ECH-associated protein 1; NFκB: nuclear factor κB; NSAIDs: nonsteroidal anti-inflammatory drugs; STATs: signal transducers and activators of transcription; TGFβ: transforming growth factor-β; VEGF: vascular endothelial growth factor.